Try our Advanced Search for more refined results
Private Equity
-
February 16, 2024
Soroc Tech Del. Suit Alleges Fraud In $115M DecisionOne Deal
Canada-based information technology services provider Soroc Technology Holdings LLC has sued private equity firm Oak Lane Partners and several of its top officers and affiliates in Delaware's Court of Chancery, alleging they were behind an elaborate, $115 million company sale fraud that snared Soroc.
-
February 16, 2024
Startup Countersues Trucker Tracking Co. For Stealing Tech
A venture capital-backed startup that sells dashboard cameras to monitor truck drivers is responding to a rival's well-publicized patent infringement case by filing its own patent lawsuit in a different federal court that mirrors many of the same allegations of technological theft but pointing them in the other direction.
-
February 16, 2024
Canada Liable Under NAFTA For Axed LNG Project, Co. Says
A U.S. company that invested at least $120 million in a since-thwarted liquefied natural gas project maintained that Canada is liable for $1 billion in damages for breaches of the North American Free Trade Agreement, and that the International Centre for Settlement of Investment Disputes has jurisdiction over its claims.
-
February 16, 2024
Catching Up With Delaware's Chancery Court
News broke last week that Delaware's Court of Chancery will say goodbye to its current longest-serving jurist, a development that quickly overshadowed a busy week of new merger and board disputes, fee rulings, settlements, and books-and-records demands.
-
February 16, 2024
French Retail Co. Casino Group Files For Ch. 15 Recognition
French retail conglomerate Casino Guichard-Perrachon SA filed for Chapter 15 bankruptcy in New York, seeking recognition of a French insolvency proceeding designed to slash more than €1.5 billion ($1.6 billion) from its debt sheet.
-
February 16, 2024
Chromocell Hits Stock Markets Following $6.6M IPO
Clinical-stage biotechnology company Chromocell Therapeutics Corp. began trading publicly on Friday after raising $6.6 million in its initial public offering, becoming the latest in a flurry of biotech IPOs.
-
February 16, 2024
Taxation With Representation: Paul Weiss, Kirkland
In this week's Taxation With Representation, Diamondback buys Endeavor, KKR & Co. acquires a stake in Cotiviti, and Gilead Sciences Inc. purchases CymaBay Therapeutics Inc.
-
February 16, 2024
Gibson Dunn, DLA Piper Steer $1.45B Sale Of All3Media
RedBird IMI, advised by Gibson Dunn & Crutcher LLP, on Friday revealed that it has agreed to buy independent television production and distribution company All3Media from its joint owners, DLA Piper-led Warner Bros. Discovery Inc. and Liberty Global Ltd., in a £1.15 billion ($1.45 billion) deal that will allow the independent production company to continue developing and producing programming.
-
February 16, 2024
Paul Weiss-Led PE Firms Buying HireRight In $1.65B Deal
Paul Weiss Rifkind Wharton & Garrison LLP is guiding private equity firms General Atlantic and Stone Point Capital on a $1.65 billion deal to purchase all the outstanding shares of HireRight Holdings Corp. they do not already own, HireRight said in a statement Friday.
-
February 16, 2024
Lawyers Advising PE On Alternative Exits Amid Market Slump
Private equity firms have turned to their lawyers to find creative solutions for realizing cash for investors as deals activity in the IPO market in London remains sluggish — such as setting up continuation funds, making partial sales or working creatively with debt.
-
February 15, 2024
7th Circ. Rejects Ancestry.com's Arbitration Bid In Privacy Suit
The Seventh Circuit on Thursday upheld a lower court's decision that minors suing Ancestry.com for sharing their genetic testing information can avoid arbitration, saying there was no language in the terms their parents signed designating the children as parties to the agreement.
-
February 15, 2024
Shoppers Say Albertsons-Kroger Suit Shortcomings Fixed
Consumers challenging Kroger's $24.6 billion bid for Albertsons defended their revised lawsuit in California federal court against the supermarkets' latest dismissal bid, arguing their tweaked complaint now adequately identifies the affected stores and lays out how the deal threatens competition.
-
February 15, 2024
Citadel Securities, Others Beat Biotech Spoofing Suit, For Now
A New York federal judge has adopted in full a magistrate judge's recommendation to toss a suit accusing several broker-dealers, including Citadel Securities LLC and Virtu Americas LLC, of carrying out a spoofing scheme that repeatedly drove a biotechnology company's share price down, saying he agrees with the report's finding that the suit fails to show that the alleged scheme caused lower stock prices in every instance.
-
February 15, 2024
Baker McKenzie Can't Send Malpractice Suit To London
An Illinois state appeals court has rejected a push by Chicago-based Baker McKenzie to transfer to London a legal malpractice suit accusing the international law firm of botching a client's bid to reacquire a coal mine in Russia, saying in a 2-1 decision that Cook County has an interest in deciding the case even if the alleged misconduct stems from attorneys in a Russian member firm.
-
February 15, 2024
Trian Decries Disney's 'Spaghetti-Against-The-Wall' Strategy
Walt Disney Co. shareholder and activist investor The Trian Group is taking a public swipe at the company's performance, criticizing its "fairy tale" and "spaghetti-against-the-wall" strategy to improve profits.
-
February 15, 2024
Freenome Raises $254M For Early Cancer Detection Tests
Cancer-focused biotechnology company Freenome said Thursday it has raised $254 million from investors to advance cancer detection tests in its pipeline.
-
February 15, 2024
Aurinia Refocusing After Failed Effort To Find A Buyer
Kidney-focused biotech Aurinia Pharmaceuticals is hitting pause on drug development, cutting jobs and initiating a $150 million stock buyback program, the company disclosed in its year-end financial report Thursday.
-
February 15, 2024
Lawmakers Push PE Firm For Answers On Steward Health
A group of lawmakers demanded answers from private equity firm Cerberus Capital Management on Thursday over its relationship with financially troubled Steward Health Care-owned hospitals in Massachusetts, saying that Steward's recent collapse is a "textbook example" of the "grave risks" that come with private equity takeover of the healthcare system.
-
February 15, 2024
FTC's Khan Calls Healthcare 'Key' To Fight For Competition
Federal Trade Commission Chair Lina Khan told a conference of physicians the agency is fighting corporate control at several levels of the healthcare industry, touting the sector as a key battleground in the administration's push for more competition across the economy.
-
February 15, 2024
Trump Social Media Blank-Check Merger Gets SEC Approval
The blank-check company looking to take former President Donald Trump's social media platform public has obtained approval from the U.S. Securities and Exchange Commission to move forward with the long-delayed merger, according to a recent regulatory filing.
-
February 15, 2024
Starwood Capital Injects $850M Into Echelon Data Centres
Real estate-focused private investment firm Starwood Capital Group on Thursday revealed that it acquired a 50% stake in Dublin, Ireland-based Echelon Data Centres through an $850 million investment, valuing Echelon at roughly €2.5 billion ($2.69 billion) in a deal built by three firms.
-
February 15, 2024
Deals Rumor Mill: Sony-Michael Jackson, Inspire IPO, Walmart
Sony plans to acquire half of Michael Jackson's catalog; private equity firm Roark Capital is planning to list Inspire Brands, which owns Dunkin' and other food chains; and Walmart is pursuing an acquisition of TV maker Vizio. Here, Law360 breaks down these and other notable deal rumors from the past week.
-
February 14, 2024
Campbell Soup Says It Gave FTC Info For $2.7B Sauce Deal
Campbell Soup Co. has given the Federal Trade Commission all the information the agency has asked for concerning its planned acquisition of Sovos Brands, the owner of the popular sauce brand Rao, before the agency decides whether to give the $2.7 billion union its blessing.
-
February 14, 2024
Insurer Needn't Defend Landlord From Antitrust MDL
A Washington state judge has ruled in favor of an insurer in a coverage dispute revolving around nearly 40 antitrust class action claims against landlords that have been combined into a multidistrict litigation case, finding that the insurer owes no defense coverage to an accused property manager.
-
February 14, 2024
Adagio Medical Goes Public In $128M SPAC Merger
Adagio Medical, a catheter ablation tech maker, and Arya Sciences, a special purpose acquisition company, said on Wednesday that they would merge, taking the combined company public at a $128 million value, guided by respective legal adviser Reed Smith and Kirkland.
Expert Analysis
-
Unpacking Recent Changes At The NY Federal Reserve
After recent changes at the Federal Reserve Bank of New York, certain money market mutual funds that previously relied on the Overnight Reverse Repo Facility will be expected to place cash with a commercial bank or invest directly in assets, which in turn supports the functioning of the real economy, say attorneys at Mayer Brown.
-
Some Client Speculations On AI And The Law Firm Biz Model
Generative artificial intelligence technologies will put pressure on the business of law as it is structured currently, but clients may end up with more price certainty for legal services, and lawyers may spend more time being lawyers, says Jonathan Cole at Melody Capital.
-
Private Equity Firms Shouldn't Overlook Cybersecurity Risks
Given the operational, financial and reputational costs at stake, and the growing threat of cybercrime, cybersecurity should be central to deal making, internal governance and post-acquisition management for private equity firms, say Ray Bogenrief and William Ridgway at Skadden.
-
Assessing Overlapping Boards After DOJ Crackdown
The U.S. Department of Justice’s recent targeting of interlocking directorates raises questions about the scope of applicable antitrust law, including when companies will be considered competitors, whether the statute reaches potential competitors, and how companies can avoid price-fixing or market allocation charges, say attorneys at Cooley.
-
NY AG's Digital Asset Proposal Shouldn't Be Taken Lightly
Given New York state's prominence both in the digital asset industry and as a proving ground for state regulatory innovation, all digital asset industry participants should take seriously New York Attorney General Letitia James' legislative proposal to tighten crypto regulation, say attorneys at WilmerHale.
-
Lessons On Corporate Fiduciary Duties From Del. M&A Case
The recent decision in New Enterprise Associates v. Rich, which held that a contractual covenant by certain stockholders not to challenge specific sales of the company was enforceable, highlights that the Delaware Court of Chancery generally is likely to be receptive to waivers of fiduciary duties that are agreed by sophisticated stockholders, say attorneys at Fried Frank.
-
Failed Tegna Deal Reveals Increasing Merger Review Hurdles
A deeper look at how the Tegna-Standard General deal derailed during merger review suggests some practical steps that firms should consider to close transactions when dealing with multiple federal agencies operating under a whole-of-government antitrust enforcement approach, say Jody Boudreault and Katherine Dutcher at Baker Botts.
-
A Lawyer's Guide To Approaching Digital Assets In Discovery
The booming growth of cryptocurrency and non-fungible tokens has made digital assets relevant in many legal disputes but also poses several challenges for discovery, so lawyers must garner an understanding of the technology behind these assets, the way they function, and how they're held, says Brett Sager at Ehrenstein Sager.
-
Opinion
High Court's Ethics Statement Places Justices Above The Law
The U.S. Supreme Court justices' disappointing statement on the court's ethics principles and practices reveals that not only are they satisfied with a status quo in which they are bound by fewer ethics rules than other federal judges, but also that they've twisted the few rules that do apply to them, says David Janovsky at the Project on Government Oversight.
-
A Look At Corwin Cleansing After Chancery Edgio Ruling
The Delaware Chancery Court's denial of Corwin cleansing in an action seeking post-closing injunctive relief in the Edgio stockholders case has potentially significant implications for corporations and their boards in the negotiation of investment agreements with significant stockholders, say attorneys at Cleary.
-
Opinion
Time For Law Schools To Rethink Unsung Role Of Adjuncts
As law schools prepare for the fall 2023 semester, administrators should reevaluate the role of the underappreciated, indispensable adjunct, and consider 16 concrete actions to improve the adjuncts' teaching experience, overall happiness and feeling of belonging, say T. Markus Funk at Perkins Coie, Andrew Boutros at Dechert and Eugene Volokh at UCLA.
-
4 Areas Of Heightened Antitrust Risk In Private Equity
Antitrust enforcement and litigation are moving from portfolio companies to the private equity firms that invest in them, and a few areas of elevated risk stand out, say Ann O’Brien and Lindsey Collins at Sheppard Mullin.
-
Tips For In-House Legal Leaders In A Challenging Economy
Amid today's economic and geopolitical uncertainty, in-house legal teams are running lean and facing increased scrutiny and unique issues, but can step up and find innovative ways to manage outcomes and capitalize on good business opportunities, says Tim Parilla at LinkSquares.
-
M&A Considerations For European Cos. Acquiring US Entities
As investment banks forecast a resurgence of mergers and acquisitions later this year, European companies seeking to acquire U.S. businesses should be aware of key procedural differences and federal regulatory requirements that will affect the process, timing and terms of the transaction, say attorneys at Mintz.
-
Compliance Considerations For Financial Institutions Using AI
Financial institutions that adopt innovative and disruptive artificial intelligence technology to improve their offerings in the coming months will need to take appropriate steps to ensure they remain on the right side of any lines drawn by U.S. and international regulators, say Timothy Spangler and Linda Ann Bartosch at Dechert.